# CAPR PDUFA Calendar: FDA Decision Dates & Catalyst Timeline

Canonical URL: https://biopharmsignal.com/pdufa-calendar/CAPR
Company: Capricor Therapeutics

BioPharmSignal tracks active PDUFA and FDA decision milestones associated with CAPR.

## CAPR PDUFA Milestones

- 2025-07-11 — CRL — FDA issued Complete Response Letter. The sponsor reported that FDA issued a Complete Response Letter for Deramiocel on July 11, 2025. This list-only historic...
  Company: Capricor Therapeutics
  Source: https://www.sec.gov/Archives/edgar/data/0001133869/000155837025009186/capr-20250711xex99d1.htm
  Event detail: https://biopharmsignal.com/pdufa-calendar/CAPR/deramiocel-deramiocel-bla.md
  Month page: https://biopharmsignal.com/pdufa-calendar/2025/july (July 2025)

## Related Pages

- Company page: https://biopharmsignal.com/company/CAPR
- Interactive PDUFA Calendar: https://biopharmsignal.com/pdufa-calendar

## FAQ

### What does the CAPR PDUFA calendar show?

It shows active PDUFA and FDA decision milestones associated with CAPR, including decision dates, application stage, and summary details when available.
### Where can I find more context for CAPR?

Use the BioPharmSignal company page for CAPR to read related news, stock data, sector context, and company-specific updates.
### Are these dates investment advice?

No. PDUFA dates are research inputs, not investment recommendations. Always review primary sources and understand the clinical and regulatory context.